581 related articles for article (PubMed ID: 11085519)
21. Investigation of glucocorticoid-induced apoptotic pathway: processing of caspase-6 but not caspase-3.
Miyashita T; Nagao K; Krajewski S; Salvesen GS; Reed JC; Inoue T; Yamada M
Cell Death Differ; 1998 Dec; 5(12):1034-41. PubMed ID: 9894610
[TBL] [Abstract][Full Text] [Related]
22. Merbarone, a catalytic inhibitor of DNA topoisomerase II, induces apoptosis in CEM cells through activation of ICE/CED-3-like protease.
Khélifa T; Beck WT
Mol Pharmacol; 1999 Mar; 55(3):548-56. PubMed ID: 10051540
[TBL] [Abstract][Full Text] [Related]
23. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.
Yu W; Simmons-Menchaca M; You H; Brown P; Birrer MJ; Sanders BG; Kline K
Mol Carcinog; 1998 Aug; 22(4):247-57. PubMed ID: 9726817
[TBL] [Abstract][Full Text] [Related]
24. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
[TBL] [Abstract][Full Text] [Related]
25. Developmental differences in HO-induced oligodendrocyte cell death: role of glutathione, mitogen-activated protein kinases and caspase 3.
Fragoso G; Martínez-Bermúdez AK; Liu HN; Khorchid A; Chemtob S; Mushynski WE; Almazan G
J Neurochem; 2004 Jul; 90(2):392-404. PubMed ID: 15228596
[TBL] [Abstract][Full Text] [Related]
26. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of caspase or FADD function blocks proliferation but not MAP kinase-activation and interleukin-2-production during primary stimulation of T cells.
Mack A; Häcker G
Eur J Immunol; 2002 Jul; 32(7):1986-92. PubMed ID: 12115619
[TBL] [Abstract][Full Text] [Related]
28. Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2.
Guo H; Tittle TV; Allen H; Maziarz RT
Exp Cell Res; 1998 Nov; 245(1):57-68. PubMed ID: 9828101
[TBL] [Abstract][Full Text] [Related]
29. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
30. Interferon-regulatory factor-1 is critical for tamoxifen-mediated apoptosis in human mammary epithelial cells.
Bowie ML; Dietze EC; Delrow J; Bean GR; Troch MM; Marjoram RJ; Seewaldt VL
Oncogene; 2004 Nov; 23(54):8743-55. PubMed ID: 15467738
[TBL] [Abstract][Full Text] [Related]
31. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
Wu SJ; Ng LT; Lin CC
Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
[TBL] [Abstract][Full Text] [Related]
32. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells.
Motwani M; Delohery TM; Schwartz GK
Clin Cancer Res; 1999 Jul; 5(7):1876-83. PubMed ID: 10430095
[TBL] [Abstract][Full Text] [Related]
33. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells.
Chen C; Shen G; Hebbar V; Hu R; Owuor ED; Kong AN
Carcinogenesis; 2003 Aug; 24(8):1369-78. PubMed ID: 12819184
[TBL] [Abstract][Full Text] [Related]
34. Baculovirus p35 and Z-VAD-fmk inhibit thapsigargin-induced apoptosis of breast cancer cells.
Qi XM; He H; Zhong H; Distelhorst CW
Oncogene; 1997 Sep; 15(10):1207-12. PubMed ID: 9294614
[TBL] [Abstract][Full Text] [Related]
35. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
[TBL] [Abstract][Full Text] [Related]
36. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
Hu H; Jiang C; Ip C; Rustum YM; Lü J
Clin Cancer Res; 2005 Mar; 11(6):2379-88. PubMed ID: 15788689
[TBL] [Abstract][Full Text] [Related]
37. Polyamines are required for activation of c-Jun NH2-terminal kinase and apoptosis in response to TNF-alpha in IEC-6 cells.
Bhattacharya S; Ray RM; Viar MJ; Johnson LR
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G980-91. PubMed ID: 12869386
[TBL] [Abstract][Full Text] [Related]
38. Caspase-3 activation during apoptosis caused by glutathione-doxorubicin conjugate.
Asakura T; Sawai T; Hashidume Y; Ohkawa Y; Yokoyama S; Ohkawa K
Br J Cancer; 1999 May; 80(5-6):711-5. PubMed ID: 10360648
[TBL] [Abstract][Full Text] [Related]
39. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation.
MacFarlane M; Cohen GM; Dickens M
Biochem J; 2000 May; 348 Pt 1(Pt 1):93-101. PubMed ID: 10794718
[TBL] [Abstract][Full Text] [Related]
40. Evidence that non-caspase proteases are required for chromatin degradation during apoptosis.
Hughes FM; Evans-Storms RB; Cidlowski JA
Cell Death Differ; 1998 Dec; 5(12):1017-27. PubMed ID: 9894608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
